Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
3
self-reported 2–10 band
Founded
Not recorded
Legal entities
1
ACRA
Office countries
1
1 address
Funding rounds
1
Series A · May 2017
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 confirmed entity
ENLEOFEN BIO PTE. LTD.Entity record →
UEN201709350D
Legal entities
Show as table · Enleofen Bio: 1 registry entity
| ENLEOFEN BIO PTE. LTD. | UEN 201709350D |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Enleofen Bio is a biotechnology company that focuses on developing first-in-class antibody therapeutics for the treatment of fibrotic human diseases. Following the breakthrough discovery in the importance of interleukin 11 as a main driver of fibrosis, Enleofen was founded as a spin-out from National Heart Centre Singapore, SingHealth and Duke-NUS Medical School with Series A funding to translate research findings into treatments that will improve and save the lives of millions of patients worldwide.
We aim to develop our lead antibodies in clinical trials within a two-year time frame with the goal of creating a drug that can be used to treat multiple diseases for which there are currently no treatment options. You can find out more about Enleofen by visiting our website at https://www.enleofen.com/.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
Addresses
- SG160 Robinson Road; SBF Center, #23-02; Singapore, Singapore 068914Primary
Grid intelligence Members
Funding
Last round · 4 May 2017Amount not recordedSeries A
Rounds1
Round typeSeries A · venture round
Amount (USD)not recorded
Stage rank3
Investors named0
Since last round8 yr 8 mo
Funding
Show as table · 1 funding round
| Rounds | 1 |
|---|---|
| Axis | 2017 to 2026 |
| Series A · 4 May 2017 | not disclosed |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
2 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
FAQ
Which legal entity operates under Enleofen Bio?
One Singapore entity on ACRA. ENLEOFEN BIO PTE. LTD. (UEN 201709350D), high confidence.
How many people work at Enleofen Bio?
The record holds 3 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Where does Enleofen Bio have offices?
One address on record, Singapore only. Primary: 160 Robinson Road, SBF Center, #23-02, Singapore 068914.
Has Enleofen Bio raised funding?
One round. Latest 4 May 2017: Series A, no amount recorded.
Which companies are listed alongside Enleofen Bio?
Six peer profiles on record: Aligma and TAPP! Global.